Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Vittoria Biotherapeutics is a gene-edited cell therapeutics company.
Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.
Quell Therapeutics is a cell therapy company
Ervaxx is illuminating the immune interface to develop new cancer therapies.
Miach Orthopaedics is a medical device company that designs technologies intended to facilitate new tissue growth.
Brixton Biosciences is a clinical-stage life sciences company that develops therapies for chronic and acute pain.
Clarify Medical is a developer of a handheld medical device used to treat psoriasis, eczema, and vitiligo .
Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.
Transposon Therapeutics specializes in developing therapeutics for debilitating and life-threatening diseases.
TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.
Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.
X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.
KalVista Pharmaceuticals is an ophthalmology company focused on developing drugs for the treatment of diabetic macular edema (DME).
Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders
Draig Therapeutics is a clinical-stage biopharmaceutical startup.
Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.
Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.
AdvanCell is a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer treatment.
Perfuze is a medical device company developing catheter-based aspiration technology to treat acute ischemic stroke.
Ria Health is an online platform providing telehealth services for alcohol use disorder.
Harness Therapeutics is a developer of a platform for physiological upregulation of proteins using targeted translation enhancers, SINEUPs.
LoQus23 is a DDF-formed company focussing on targeting DNA damage repair pathways to treat Huntington’s disease.
Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases.
Eyebiotech is an ophthalmology biotechnology company that specializes in therapies for eye diseases.
SV Health Investors has invested in 76 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
SV Health Investors's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Health Diagnostics. The firm invests across 20 different industry categories.
Among tracked funding rounds, Quell Therapeutics received $156.0M in a Series B round. SV Health Investors's total known invested capital is $1.9B.
SV Health Investors's average investment size is $34.1M across its portfolio of 76 companies.
Recent SV Health Investors portfolio additions include Vittoria Biotherapeutics, Pulmocide, Quell Therapeutics, Enara Bio, Miach Orthopaedics. These companies were founded in 2020 or later.